| Primary |
| Drug Use For Unknown Indication |
21.9% |
| Premedication |
10.9% |
| Prophylaxis Of Nausea And Vomiting |
9.9% |
| Product Used For Unknown Indication |
9.1% |
| Breast Cancer |
5.7% |
| Nausea |
5.5% |
| Colon Cancer Metastatic |
5.2% |
| Rectal Cancer Metastatic |
4.2% |
| Vomiting |
3.6% |
| Lymphoma |
3.4% |
| Chemotherapy |
3.1% |
| Hypertension |
3.1% |
| Anaesthesia |
2.6% |
| Rectal Cancer |
2.3% |
| Antiemetic Supportive Care |
2.1% |
| Colon Cancer |
1.8% |
| Non-hodgkin's Lymphoma |
1.8% |
| Uterine Neoplasm |
1.6% |
| Colorectal Cancer |
1.0% |
| Diffuse Large B-cell Lymphoma |
1.0% |
|
| Death |
16.7% |
| Vomiting |
11.9% |
| Rhabdomyolysis |
7.1% |
| Convulsion |
6.0% |
| Hepatitis |
6.0% |
| Cardio-respiratory Arrest |
4.8% |
| Hyperglycaemia |
4.8% |
| Serotonin Syndrome |
4.8% |
| Visual Disturbance |
4.8% |
| Infection |
3.6% |
| Myocardial Infarction |
3.6% |
| Renal Cancer Metastatic |
3.6% |
| Tremor |
3.6% |
| Weight Decreased |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Anaphylactic Shock |
2.4% |
| Blindness Unilateral |
2.4% |
| Epilepsy |
2.4% |
| Hepatitis Cholestatic |
2.4% |
| Ileus |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
13.7% |
| Premedication |
12.1% |
| Nausea |
11.9% |
| Product Used For Unknown Indication |
10.3% |
| Pain |
6.3% |
| Breast Cancer |
5.8% |
| Prophylaxis |
5.4% |
| Oesophageal Carcinoma |
3.7% |
| Constipation |
3.5% |
| Prophylaxis Of Nausea And Vomiting |
3.2% |
| Colon Cancer |
3.1% |
| Vomiting |
3.0% |
| Bacterial Infection |
2.8% |
| Rectal Cancer |
2.8% |
| Chemotherapy |
2.6% |
| Colon Cancer Metastatic |
2.3% |
| Colorectal Cancer |
2.1% |
| Colorectal Cancer Metastatic |
1.9% |
| Lymphoma |
1.8% |
| Proctalgia |
1.8% |
|
| Vomiting |
13.7% |
| Shock |
7.8% |
| Anaphylactic Shock |
6.9% |
| Headache |
6.9% |
| Hypertension |
6.9% |
| Abdominal Pain |
5.9% |
| Convulsion |
4.9% |
| Flushing |
4.9% |
| Hepatitis |
4.9% |
| Malaise |
3.9% |
| Nausea |
3.9% |
| Renal Failure Acute |
3.9% |
| Swollen Tongue |
3.9% |
| Thrombocytopenia |
3.9% |
| Large Intestine Perforation |
2.9% |
| Myocardial Infarction |
2.9% |
| Pneumonia Fungal |
2.9% |
| Postoperative Wound Complication |
2.9% |
| Rash |
2.9% |
| Skin Exfoliation |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.2% |
| Prophylaxis |
16.8% |
| Product Used For Unknown Indication |
10.4% |
| Premedication |
8.1% |
| Multiple Myeloma |
5.0% |
| Breast Cancer |
4.4% |
| Colon Cancer |
4.1% |
| Nausea |
3.7% |
| Colorectal Cancer |
3.4% |
| Rectal Cancer |
3.2% |
| Prophylaxis Of Nausea And Vomiting |
3.1% |
| Hypertension |
3.0% |
| Non-small Cell Lung Cancer |
2.8% |
| Pain |
2.7% |
| Constipation |
2.5% |
| Colon Cancer Metastatic |
2.1% |
| Neoplasm Malignant |
2.1% |
| Breast Cancer Metastatic |
1.9% |
| Stem Cell Transplant |
1.9% |
| Infection Prophylaxis |
1.6% |
|
| White Blood Cell Count Decreased |
17.5% |
| Vomiting |
15.9% |
| Pyrexia |
6.3% |
| Sepsis |
5.9% |
| Pneumonia |
5.7% |
| Thrombocytopenia |
5.2% |
| Weight Decreased |
4.7% |
| Interstitial Lung Disease |
4.5% |
| Stomatitis |
3.9% |
| Neutropenia |
3.8% |
| Rash |
3.3% |
| Febrile Neutropenia |
3.2% |
| Neutrophil Count Decreased |
3.2% |
| Death |
2.7% |
| Nausea |
2.7% |
| White Blood Cell Count Increased |
2.6% |
| Respiratory Failure |
2.3% |
| Haemoglobin Decreased |
2.3% |
| Platelet Count Decreased |
2.2% |
| Diarrhoea |
2.1% |
|
| Interacting |
| Non-hodgkin's Lymphoma |
100.0% |
|
|
